O

Ocular Therapeutix

Hydrogel-based ocular drug delivery platform

Assistant Corporate Controller

Financial AccountingConfirmed live in the last 24 hours
Full-timeBedford, MA, USA$225k - $275k

About the Job

Requirements

  • A bachelor's degree in accounting is required.
  • CPA certification is preferred.
  • At least 15 years of prior related experience is required.
  • Previous public accounting experience and experience at a mid-sized public biotech or pharmaceutical company are preferred.
  • Strong knowledge of U.S. generally accepted accounting principles (GAAP), SEC reporting requirements, and accounting and financial concepts relevant to publicly traded companies is required.
  • Experience with general month-end close operations, accruals, and reconciliations is required.
  • In-depth knowledge of Sarbanes-Oxley (SOX) and demonstrated ability to implement and maintain financial controls, accounting policies, and procedures is required.
  • Ability to exercise judgment, with strong analytical and problem-solving skills, and balance attention to detail with broader strategic context is required.
  • Strong project management skills and experience, including prioritizing multiple initiatives concurrently with accuracy and attention to detail, are required.
  • Ability to work collaboratively and consultatively in a fast-paced, dynamic environment is required.

Responsibilities

  • Lead, supervise, and mentor the accounting team to ensure an accurate and timely monthly, quarterly, and annual financial close.
  • Drive talent development, succession planning, and organizational scalability.
  • Review monthly close deliverables, including journal entries, reconciliations, and supporting schedules, for completeness and accuracy.
  • Ensure timely and accurate production of internal and external financial statements.
  • Maintain compliance with U.S. GAAP and monitor emerging accounting standards and SEC guidance.
  • Prepare and review SEC filings, including Forms 10-K, 10-Q, and 8-K, ensuring accuracy, completeness, and compliance with disclosure requirements.
  • Serve as the primary liaison with external auditors during quarterly reviews and the annual audit process; prepare schedules and supporting documentation.
  • Collaborate with cross-functional business and technical teams on accounting initiatives and operational alignment.
  • Partner with the financial planning and analysis team to analyze financial performance and ensure consistency between reporting and forecasting.
  • Provide technical accounting guidance, particularly for revenue recognition related to product sales and collaboration agreements, research and development expense accounting, inventory valuation, and debt and equity arrangements.
  • Draft, implement, and maintain accounting policies and support accounting positions with white papers as required.
  • Lead implementation of new accounting standards and coordinate cross-functional impact assessments.
  • Support an effective internal control environment in accordance with Section 404 of the Sarbanes-Oxley Act.
  • Identify and implement process improvements to enhance financial reporting processes and optimize financial systems.

Desired Qualifications

  • CPA certification.
  • Previous experience in public accounting and at a mid-sized public biotech or pharmaceutical company.

About the Company

Ocular Therapeutix

Hydrogel-based ocular drug delivery platform

Ocular Therapeutix develops and commercializes eye therapies using a hydrogel-based drug-delivery platform. Its approach uses a biodegradable hydrogel that stays in the eye to release medicine over time, reducing the need for frequent eye drops or injections. The flagship product, DEXTENZA, is a corticosteroid insert placed by a physician after eye surgery to treat inflammation and pain, providing sustained local treatment. The company differentiates itself by offering a scalable platform that can be used to create a range of eye medications and devices for conditions such as glaucoma, retinal diseases (including wet AMD), and dry eye, rather than competing solely on one drug. Revenue comes from selling these products to physicians and surgical centers. The goal is to expand the hydrogel delivery platform into a broader pipeline of eye therapies to improve patient outcomes and adherence by delivering drugs where and when they are needed most.

Company size
201-500
Company stage
IPO
Headquarters
Bedford, MA
Founded
2006

Recently Posted Jobs

Explore more opportunities at Ocular Therapeutix

See more jobs